|
þ
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
04-3536131
|
(State or Other Jurisdiction of Incorporation or Organization)
|
(IRS Employer Identification No.)
|
45 First Avenue
|
|
Waltham, Massachusetts
|
02451
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Title of each class
|
Name of each exchange on which registered
|
Common Stock, $0.001 par value
|
NASDAQ Capital Market
|
|
Item 1A.
|
Risk Factors.
|
|
Item 1B.
|
Unresolved Staff Comments.
|
|
Item 2.
|
Properties.
|
|
Item 3.
|
Legal Proceedings.
|
|
Item 4.
|
Mine Safety Disclosures.
|
|
|
|
|
PART II
|
||
|
|
|
Item 5.
|
Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
|
|
Item 6.
|
Selected Financial Data.
|
|
Item 7.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
|
|
Item 7A.
|
Quantitative and Qualitative Disclosures About Market Risk.
|
|
Item 8.
|
Financial Statements and Supplementary Data.
|
|
Item 9.
|
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.
|
|
Item 9A.
|
Controls and Procedures.
|
|
Item 9B.
|
Other Information.
|
|
|
|
|
PART III
|
||
|
|
|
Item 10.
|
Directors, Executive Officers and Corporate Governance.
|
|
Item 11.
|
Executive Compensation.
|
|
Item 12.
|
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
|
|
Item 13.
|
Certain Relationships and Related Transactions, and Director Independence.
|
|
Item 14.
|
Principal Accountant Fees and Services.
|
|
|
|
|
PART IV
|
||
|
|
|
Item 15.
|
Exhibits and Financial Statement Schedules.
|
1.
|
Third-party laboratory verification.
The AVL California Technology Center, a long-standing research and technology partner with the international automotive industry, confirmed our results in their state-of-the-art dynamometer test cell, which was outfitted with sophisticated emissions measurement equipment.
|
2.
|
Verifying longevity and reliability in the field.
We did so by equipping one of our TECOGEN 75-kW units, already operating at a customer location in Southern California, with the Ultera low-emissions technology and a device to continuously monitor emissions. The Ultera low-emissions system operated successfully for more than 25,000 hours, approximately 3.5 years, and consistently complied with California’s stringent emission standards over the entire field testing period.
|
3.
|
Additional independent tests.
During the field test, two companies licensed in California to test emissions each verified our results at different times. The results from one of these tests, obtained in August 2011, enabled us to qualify for New Jersey’s fast-track permitting. Virtually every state nationwide requires some kind of permit related to local air quality, but New Jersey allows an exemption for systems such as ours that demonstrate superior emissions performance. This certification was granted in November 2011, and since then we have sold Ultera low-emissions systems to customers in the territory.
|
•
|
Commercial and industrial natural gas fueled engines from other manufacturers
|
•
|
Natural gas and biogas powered vehicle fleets - such as municipal bus fleets
|
•
|
Small industrial mobile engines - such as propane powered fork trucks
|
|
2015
|
|
2014
|
||||
Products:
|
|
|
|
|
|
||
Cogeneration
|
$
|
7,882,838
|
|
|
$
|
5,364,810
|
|
Chiller & Heat Pump
|
2,172,399
|
|
|
3,260,224
|
|
||
Total product revenue
|
10,055,237
|
|
|
8,625,034
|
|
||
Service & Parts
|
7,832,181
|
|
|
7,438,125
|
|
||
Installation Services
|
3,555,239
|
|
|
3,279,505
|
|
||
Total service revenue
|
11,387,420
|
|
|
10,717,630
|
|
||
Total revenue
|
$
|
21,442,657
|
|
|
$
|
19,342,664
|
|
•
|
Provide power when a utility grid is not available or goes out of service;
|
•
|
Reduce the customer’s total cost of purchasing electricity and other fuel;
|
•
|
Reduce emissions of criteria pollutants (NOx and CO) to near-zero levels and cut the emission of greenhouse gas such as carbon dioxide;
|
•
|
Provide reliable on-site power generation, heating and cooling services; and
|
•
|
Control maintenance costs and ensure optimal peak equipment performance.
|
•
|
Sacramento Municipal Utility District has provided test sites for the Company since 2010.
|
•
|
Southern California Gas Company and San Diego Gas & Electric Company, each a Sempra Energy subsidiary have granted us research and development contracts since 2004.
|
•
|
Department of Energy’s Lawrence Berkeley National Laboratory, research and development contracts executed since 2005, including ongoing Microgrid development work related to the InVerde.
|
•
|
Eastern Municipal Water District has co-sponsored demonstration projects to retrofit both a natural-gas powered municipal water pump engine, and a biofuel powered pumping station engine with the Ultera low emissions technology since 2012.
|
•
|
Consortium for Electric Reliability Technology Solutions executed research and development contracts, and provided a test site to the Company since 2005.
|
•
|
California Energy Commission executed research and development contracts from 2004 until March 2013.
|
•
|
The AVL California Technology Center has performed a support role in research and development contracts as well as internal research and development on our emission control system from August 2009 to November 2011.
|
•
|
9,121,326: “Assembly and method for reducing nitrogen oxides, carbon monoxide and hydrocarbons in exhausts of internal combustion engines.” This patent, granted in September 2015, is related to the
Ultera
emission control system applicable to all our products.
|
•
|
8,829,698: “Power generation systems.” This patent, granted in September 2014, is for a power generation system that includes an internal combustion engine configured to provide rotational mechanical energy.
|
•
|
8,578,704: “Assembly and method for reducing nitrogen oxides, carbon monoxide, and hydrocarbons in exhausts of internal combustion engines.” This patent, granted in November 2013, is for the
Ultera
emission system applicable to all our products.
|
•
|
7,239,034: “Engine driven power inverter system with cogeneration.” This patent, granted in July 2007, pertains to the utilization of an engine-driven CHP module combined with an inverter and applies to our
InVerde
product specifically.
|
•
|
7,243,017: “Method for controlling internal combustion engine emissions.” This patent, granted in July 2007, applies to the specific algorithms used in our engine controller for metering the fuel usage to obtain the correct combustion mixture and is technology used by most of our engines.
|
•
|
"Systems and methods for reducing emissions in exhaust of vehicles and producing electricity." This patent, filed in November 2015 and published in March 2016, is related to the development of the
Ultera
emission control system for vehicle applications.
|
•
|
Product safety certifications and interconnection requirements;
|
•
|
Air pollution regulations, which govern the emissions allowed in engine exhaust;
|
•
|
State and federal incentives for CHP technology;
|
•
|
Various local building and permitting codes and third party certifications; and
|
•
|
Electric utility pricing and related regulations.
|
•
|
results and timing of our product development;
|
•
|
results of the development of our competitors’ products;
|
•
|
regulatory actions with respect to our products or our competitors’ products;
|
•
|
actual or anticipated fluctuations in our financial condition and operating results;
|
•
|
actual or anticipated changes in our growth rate relative to our competitors;
|
•
|
actual or anticipated fluctuations in our competitors’ operating results or changes in their growth rate;
|
•
|
competition from existing products or new products that may emerge;
|
•
|
announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures, collaborations, or capital commitments;
|
•
|
issuance of new or updated research or reports by securities analysts;
|
•
|
fluctuations in the valuation of companies perceived by investors to be comparable to us;
|
•
|
share price and volume fluctuations attributable to inconsistent trading volume levels of our shares;
|
•
|
additions or departures of key management or personnel;
|
•
|
disputes or other developments related to proprietary rights, including patents, litigation matters, and our ability to obtain, maintain, defend or enforce proprietary rights relating to our products and technologies;
|
•
|
announcement or expectation of additional financing efforts;
|
•
|
sales of our Common Stock by us, our insiders, or our other stockholders; and
|
•
|
general economic and market conditions.
|
•
|
have an auditor report on our internal controls over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act;
|
•
|
comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (i.e., an auditor discussion and analysis);
|
•
|
submit certain executive compensation matters to shareholder non-binding advisory votes;
|
•
|
submit for shareholder approval golden parachute payments not previously approved; and
|
•
|
disclose certain executive compensation related items such as the correlation between executive compensation and financial performance and comparisons of the Chief Executive Officer’s compensation to median employee compensation, when such disclosure requirements are adopted.
|
Year Ended December 31, 2015
|
|
High
|
|
Low
|
||||
1st Quarter
|
|
$
|
5.65
|
|
|
$
|
4.55
|
|
2nd Quarter
|
|
5.19
|
|
|
3.90
|
|
||
3rd Quarter
|
|
4.40
|
|
|
2.80
|
|
||
4th Quarter
|
|
4.10
|
|
|
2.46
|
|
Year Ended December 31, 2014
|
|
High
|
|
Low
|
||||
2nd Quarter
|
|
$
|
31.31
|
|
|
$
|
5.06
|
|
3rd Quarter
|
|
8.18
|
|
|
4.97
|
|
||
4th Quarter
|
|
7.80
|
|
|
4.59
|
|
|
Number of securities to be issued upon exercise of outstanding options, warrants and rights
|
Weighted-average exercise price of outstanding options, warrants and rights
|
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))
|
Plan Category
|
(a)
|
(b)
|
(c)
|
Equity compensation plans approved by security holders
(1)
|
1,268,200
|
$3.06
|
1,614,533
|
Equity compensation plans not approved by security holders
|
—
|
—
|
—
|
Total
|
1,268,200
|
$3.06
|
1,614,533
|
|
Years ended December 31,
|
||||
|
2015
|
|
2014
|
||
Revenues
|
100.0
|
%
|
|
100.0
|
%
|
Cost of Sales
|
64.4
|
|
|
66.9
|
|
Gross Profit
|
35.6
|
|
|
33.1
|
|
General and administrative
|
37.3
|
|
|
37.6
|
|
Selling
|
7.9
|
|
|
9.3
|
|
Research and development
|
2.8
|
|
|
5.4
|
|
Loss from operations
|
(12.4
|
)
|
|
(19.2
|
)
|
Total other expense, net
|
(0.7
|
)
|
|
(0.9
|
)
|
Consolidated net loss
|
(13.1
|
)
|
|
(20.1
|
)
|
Less: Loss attributable to the noncontrolling interest
|
0.3
|
|
|
0.6
|
|
Net loss attributable to Tecogen Inc.
|
(12.8
|
)
|
|
(19.5
|
)
|
(a)
|
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
|
(b)
|
Exhibits
|
|
TECOGEN INC.
|
|
|
(Registrant)
|
|
|
|
|
|
By:
|
/s/ John N. Hatsopoulos
|
|
Co-Chief Executive Officer
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
By:
|
/s/ Benjamin Locke
|
|
Co-Chief Executive Officer
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
By:
|
/s/ David A. Garrison
|
|
Chief Financial Officer, Treasurer and Secretary
|
|
|
(Principal Financial and Accounting Officer)
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
/s/ Angelina M. Galiteva
|
|
Chairman of the Board
|
|
March 30, 2016
|
Angelina M. Galiteva
|
|
|
|
|
|
|
|
|
|
/s/ John N. Hatsopoulos
|
|
Director and Co-Chief Executive Officer
|
|
March 30, 2016
|
John N. Hatsopoulos
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
/s/ Benjamin Locke
|
|
Co-Chief Executive Officer
|
|
March 30, 2016
|
Benjamin Locke
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
/s/ David A. Garrison
|
|
Chief Financial Officer, Treasurer and Secretary
|
|
March 30, 2016
|
David A. Garrison
|
|
(Principal Financial and Accounting Officer)
|
|
|
|
|
|
|
|
/s/ Charles T. Maxwell
|
|
Director
|
|
March 30, 2016
|
Charles T. Maxwell
|
|
|
|
|
|
|
|
|
|
/s/ Ahmed F. Ghoniem
|
|
Director
|
|
March 30, 2016
|
Ahmed F. Ghoniem
|
|
|
|
|
|
|
|
|
|
/s/ Joseph E. Aoun
|
|
Director
|
|
March 30, 2016
|
Joseph E. Aoun
|
|
|
|
|
|
|
|
|
|
/s/ Earl R. Lewis
|
|
Director
|
|
March 30, 2016
|
Earl R. Lewis
|
|
|
|
|
Exhibit Number
|
Description
|
|
3.1
b
|
Amended and Restated Certificate of Incorporation.
|
|
3.2
b
|
Amended and Restated Bylaws.
|
|
4.1
b
|
Specimen Common Stock Certificate of Tecogen Inc.
|
|
4.2
a
|
Form of Restricted Stock Purchase Agreement.
|
|
4.3+
b
|
Form of Stock Option Agreement.
|
|
4.5
|
Form of Warrant Agreement.
|
|
10.1+
c
|
Tecogen Inc. 2006 Stock Incentive Plan, as amended and restated on June 30, 2014 with stockholder approval on July 15, 2014.
|
|
10.2
a
|
Form of Tecogen Inc. Subscription Agreement for private placement of Common Stock.
|
|
10.7
b
|
Lease Agreement between Atlantic-Waltham Investment II, LLC, and Tecogen Inc., dated May 14, 2008.
|
|
10.8
b
|
Second Amendment to Lease Agreement between Atlantic-Waltham Investment II, LLC, and Tecogen Inc., dated January 16, 2013.
|
|
10.11
a
|
Form of Sales Representative Agreement.
|
|
10.12#
b
|
Asset Purchase Agreement with Danotek, LLC.
|
|
10.13#
b
|
Exclusive License Agreement between Tecogen Inc. and the Wisconsin Alumni Research Foundation, dated February 5, 2007.
|
|
10.14
a
|
Grant Award Number PIR-08-022, dated July 2, 2009.
|
|
10.15#
b
|
Sales Representative Agreement between American DG Energy Inc. and Ilios Dynamics, dated October 20, 2009.
|
|
10.16
b
|
First Amendment to the Sales Representative Agreement, dated November 12, 2013, between Ilios Inc. and American DG Energy Inc.
|
|
10.20
b
|
Form of Common Stock Purchase Agreement.
|
|
10.21
b
|
Senior Convertible Promissory Note, dated December 23, 2013, by Tecogen Inc. in favor of Michaelson Capital Special Finance Fund LP.
|
|
10.22
b
|
Collective Bargaining Agreement, dated February 25, 2014, between Tecogen Inc. and International Union of Operating Engineers, Local 68, 68A, 68B.
|
|
10.23
b
|
Revolving Line of Credit Agreement between Tecogen Inc. and John N. Hatsopoulos, dated March 26, 2014.
|
|
10.24
c
|
Facilities and Support Services Agreement between American DG Energy Inc. and Tecogen Inc., dated August 8, 2014.
|
|
10.26
g
|
Revolving Line of Credit Agreement between Tecogen Inc. and John N. Hatsopoulos, dated July 1, 2015.
|
|
10.28
d
|
Form of Common Stock Purchase Agreement dated August 3, 2015.
|
|
10.29
d
|
Registration Rights Agreement dated August 3, 2015.
|
|
10.30
e
|
First amendment to the Facilities and Support Services Agreement between American DG Energy Inc. and Tecogen Inc., dated Aug 7, 2015.
|
|
10.31
f
|
Joint Venture Agreement, dated December 28, 2015.
|
|
10.32
f
|
License between Tecogen and Ultra Emissions Technologies Ltd., dated December 28, 2015.
|
|
10.33
f
|
Form of subscription agreement between Tecogen and the several investors purchasing shares of Tecogen common stock and warrants, dated December 28, 2015.
|
|
10.34
f
|
Form of warrants issued pursuant to the subscription agreements described in Exhibit 10.33 hereto.
|
|
14.1
a
|
Code of Business Conduct and Ethics
|
|
21.1
b
|
List of subsidiaries
|
|
23.1*
|
Consent of Wolf & Company, P.C.
|
|
31.1*
|
Rule 13a-14(a) Certification of Co-Chief Executive Officer
|
|
31.2*
|
Rule 13a-14(a) Certification of Co-Chief Executive Officer
|
|
31.3*
|
Rule 13a-14(a) Certification of Chief Financial Officer
|
|
|
|
Exhibit Number
|
Description
|
|
32.1*
|
Section 1350 Certifications of Co-Chief Executive Officers and Chief Financial Officer
|
|
101.INS*
|
XBRL Instance Document
|
|
101.SCH*
|
XBRL Taxonomy Extension Schema
|
|
101.CAL*
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
101.DEF*
|
XBRL Taxonomy Extension Definition Linkbase
|
|
101.LAB*
|
XBRL Taxonomy Extension Label Linkbase
|
|
101.PRE*
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
|
|
|
*
|
Filed herewith.
|
|
|
|
|
#
|
Confidential Treatment has been granted for portions of this document. The confidential portions were omitted and filed separately, on a confidential basis, with the Securities and Exchange Commission.
|
|
+
|
Management contract or compensatory plan or agreement.
|
|
a
|
Incorporated by reference to the registrant’s Registration Statement on Form S-1, as amended, originally filed with the SEC on December 22, 2011 (Registration No. 333-178697).
|
|
b
|
Incorporated by reference to the registrant's Registration Statement on Form S-1, as amended, filed with the SEC on June 27, 2014 (Registration No. 333-193791).
|
|
c
|
Incorporated by reference to the registrant’s Quarterly Report on Form 10-Q, for the quarter ended June 30, 2014 as filed with the SEC on August 14, 2014.
|
|
d
|
Incorporated by reference to the registrant's Report on Form 8-K, as filed with the SEC on August 6, 2015.
|
|
e
|
Incorporated by reference to the registrant's Report on Form 8-K, as filed with the SEC on August 13, 2015.
|
|
f
|
Incorporated by reference to the registrant's Report on Form 8-K, as filed with the SEC on December 31, 2015.
|
|
g
|
Incorporated by reference to the registrant's Report on Form 8-K, as filed with the SEC on June 18, 2015.
|
|
2015
|
|
2014
|
||||
ASSETS
|
|
|
|
|
|
||
Current assets:
|
|
|
|
|
|
||
Cash and cash equivalents
|
$
|
5,486,526
|
|
|
$
|
1,186,033
|
|
Short-term investments, restricted
|
294,802
|
|
|
585,702
|
|
||
Accounts receivable, net
|
5,286,863
|
|
|
4,750,437
|
|
||
Unbilled revenue
|
1,072,391
|
|
|
696,912
|
|
||
Inventory, net
|
5,683,043
|
|
|
4,090,221
|
|
||
Due from related party
|
1,177,261
|
|
|
600,251
|
|
||
Deferred financing costs
|
48,989
|
|
|
50,201
|
|
||
Prepaid and other current assets
|
353,105
|
|
|
348,868
|
|
||
Total current assets
|
19,402,980
|
|
|
12,308,625
|
|
||
|
|
|
|
||||
Property, plant and equipment, net
|
543,754
|
|
|
658,421
|
|
||
Deferred financing costs, net of current portion
|
—
|
|
|
48,990
|
|
||
Intangible assets, net
|
1,044,611
|
|
|
1,011,300
|
|
||
Goodwill
|
40,870
|
|
|
40,870
|
|
||
Other assets
|
58,425
|
|
|
53,325
|
|
||
TOTAL ASSETS
|
$
|
21,090,640
|
|
|
$
|
14,121,531
|
|
|
|
|
|
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
||
Current liabilities:
|
|
|
|
|
|
||
Accounts payable
|
$
|
3,311,809
|
|
|
$
|
2,416,313
|
|
Accrued expenses
|
1,066,860
|
|
|
1,008,153
|
|
||
Deferred revenue
|
996,941
|
|
|
1,666,576
|
|
||
Total current liabilities
|
5,375,610
|
|
|
5,091,042
|
|
||
|
|
|
|
||||
Long-term liabilities:
|
|
|
|
|
|
||
Deferred revenue, net of current portion
|
273,162
|
|
|
207,153
|
|
||
Senior convertible promissory note, related party
|
3,000,000
|
|
|
3,000,000
|
|
||
Total liabilities
|
8,648,772
|
|
|
8,298,195
|
|
||
|
|
|
|
||||
Commitments and contingencies (Note 8)
|
|
|
|
|
|
||
|
|
|
|
||||
Stockholders’ equity:
|
|
|
|
|
|
||
Tecogen Inc. stockholders’ equity:
|
|
|
|
|
|
||
Common stock, $0.001 par value; 100,000,000 shares authorized; 18,478,990 and 15,905,881 issued and outstanding at December 31, 2015 and 2014, respectively
|
18,479
|
|
|
15,906
|
|
||
Additional paid-in capital
|
34,501,640
|
|
|
25,088,213
|
|
||
Accumulated deficit
|
(21,682,437
|
)
|
|
(18,955,023
|
)
|
||
Total Tecogen Inc. stockholders’ equity
|
12,837,682
|
|
|
6,149,096
|
|
||
Noncontrolling interest
|
(395,814
|
)
|
|
(325,760
|
)
|
||
Total stockholders’ equity
|
12,441,868
|
|
|
5,823,336
|
|
||
|
|
|
|
||||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
|
$
|
21,090,640
|
|
|
$
|
14,121,531
|
|
|
2015
|
|
2014
|
||||
Revenues
|
|
|
|
|
|
||
Products
|
$
|
10,055,237
|
|
|
$
|
8,625,034
|
|
Services
|
11,387,420
|
|
|
10,717,630
|
|
||
Total revenues
|
21,442,657
|
|
|
19,342,664
|
|
||
|
|
|
|
||||
Cost of sales
|
|
|
|
|
|
||
Products
|
7,137,149
|
|
|
6,347,583
|
|
||
Services
|
6,672,282
|
|
|
6,596,017
|
|
||
Total cost of sales
|
13,809,431
|
|
|
12,943,600
|
|
||
|
|
|
|
||||
Gross profit
|
7,633,226
|
|
|
6,399,064
|
|
||
|
|
|
|
||||
Operating expenses
|
|
|
|
|
|
||
General and administrative
|
7,997,512
|
|
|
7,264,630
|
|
||
Selling
|
1,687,479
|
|
|
1,796,268
|
|
||
Research and development
|
591,585
|
|
|
1,041,483
|
|
||
Total operating expenses
|
10,276,576
|
|
|
10,102,381
|
|
||
|
|
|
|
||||
Loss from operations
|
(2,643,350
|
)
|
|
(3,703,317
|
)
|
||
|
|
|
|
||||
Other income (expense)
|
|
|
|
|
|
||
Interest and other income
|
14,334
|
|
|
9,710
|
|
||
Interest expense
|
(171,944
|
)
|
|
(177,345
|
)
|
||
Total other expense, net
|
(157,610
|
)
|
|
(167,635
|
)
|
||
|
|
|
|
||||
Loss before income taxes
|
(2,800,960
|
)
|
|
(3,870,952
|
)
|
||
Consolidated net loss
|
(2,800,960
|
)
|
|
(3,870,952
|
)
|
||
|
|
|
|
||||
Less: Loss attributable to the noncontrolling interest
|
73,547
|
|
|
125,140
|
|
||
Net loss attributable to Tecogen Inc.
|
$
|
(2,727,413
|
)
|
|
$
|
(3,745,812
|
)
|
|
|
|
|
||||
Net loss per share - basic and diluted
|
$
|
(0.16
|
)
|
|
$
|
(0.24
|
)
|
|
|
|
|
||||
Weighted average shares outstanding - basic and diluted
|
16,860,453
|
|
|
15,607,897
|
|
|
|
Tecogen Inc.
|
|
|
|
|
|||||||||||||||||
|
|
Common Stock Shares
|
|
Common
Stock
$.001
Par Value
|
|
Additional
Paid-In
Capital
|
|
Accumulated
Deficit
|
Noncontrolling
Interest
|
Total
|
|||||||||||||
Balance at December 31, 2013
|
|
15,155,200
|
|
|
$
|
15,155
|
|
|
$
|
22,463,996
|
|
|
$
|
(15,209,212
|
)
|
|
$
|
(204,046
|
)
|
|
$
|
7,065,893
|
|
Sale of common stock
|
|
649,106
|
|
|
649
|
|
|
2,339,545
|
|
|
—
|
|
|
—
|
|
|
2,340,194
|
|
|||||
Exercise of stock options
|
|
101,575
|
|
|
102
|
|
|
161,163
|
|
|
—
|
|
|
—
|
|
|
161,265
|
|
|||||
Stock based compensation expense
|
|
—
|
|
|
—
|
|
|
123,510
|
|
|
—
|
|
|
3,426
|
|
|
126,936
|
|
|||||
Net loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,745,812
|
)
|
|
(125,140
|
)
|
|
(3,870,952
|
)
|
|||||
Balance at December 31, 2014
|
|
15,905,881
|
|
|
$
|
15,906
|
|
|
$
|
25,088,214
|
|
|
$
|
(18,955,024
|
)
|
|
$
|
(325,760
|
)
|
|
$
|
5,823,336
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Sale of common stock and warrants
|
|
2,350,734
|
|
|
2,351
|
|
|
8,857,416
|
|
|
—
|
|
|
—
|
|
|
8,859,767
|
|
|||||
Exercise of stock options
|
|
222,375
|
|
|
222
|
|
|
360,003
|
|
|
—
|
|
|
—
|
|
|
360,225
|
|
|||||
Stock based compensation expense
|
|
—
|
|
|
—
|
|
|
196,007
|
|
|
—
|
|
|
3,493
|
|
|
199,500
|
|
|||||
Net loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,727,413
|
)
|
|
(73,547
|
)
|
|
(2,800,960
|
)
|
|||||
Balance at December 31, 2015
|
|
18,478,990
|
|
|
$
|
18,479
|
|
|
$
|
34,501,640
|
|
|
$
|
(21,682,437
|
)
|
|
$
|
(395,814
|
)
|
|
$
|
12,441,868
|
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
2015
|
|
2014
|
||||
|
|
|
|
|
|||
Net loss
|
$
|
(2,800,960
|
)
|
|
$
|
(3,870,952
|
)
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
|
|
|
|
|
||
Depreciation and amortization
|
271,727
|
|
|
278,865
|
|
||
Loss (gain) on disposal of asset
|
(4,631
|
)
|
|
1,209
|
|
||
Provision for losses on accounts receivable
|
—
|
|
|
53,800
|
|
||
(Recovery) for inventory reserve
|
(7,000
|
)
|
|
—
|
|
||
Stock-based compensation
|
199,500
|
|
|
126,936
|
|
||
Non-cash interest expense
|
50,202
|
|
|
50,910
|
|
||
Changes in operating assets (increase) decrease in:
|
|
|
|
|
|
||
Short-term investments, restricted
|
290,900
|
|
|
(1,303
|
)
|
||
Accounts receivable
|
(536,426
|
)
|
|
(1,063,352
|
)
|
||
Inventory
|
(1,585,822
|
)
|
|
(746,428
|
)
|
||
Unbilled revenue
|
(375,479
|
)
|
|
(50,514
|
)
|
||
Due from related party
|
(577,010
|
)
|
|
(600,251
|
)
|
||
Prepaid expenses and other current assets
|
(4,237
|
)
|
|
(8,855
|
)
|
||
Other assets
|
(5,100
|
)
|
|
19,100
|
|
||
Changes in operating liabilities increase (decrease) in:
|
|
|
|
|
|
||
Accounts payable
|
895,496
|
|
|
78,267
|
|
||
Accrued expenses
|
58,707
|
|
|
(131,401
|
)
|
||
Deferred revenue
|
(603,626
|
)
|
|
1,055,270
|
|
||
Interest payable, related party
|
—
|
|
|
(198,450
|
)
|
||
Due to related party
|
—
|
|
|
(119,667
|
)
|
||
Net cash used in operating activities
|
(4,733,759
|
)
|
|
(5,126,816
|
)
|
||
CASH FLOWS FROM INVESTING ACTIVITIES:
|
|
|
|
|
|
||
Purchases of property and equipment
|
(69,582
|
)
|
|
(223,574
|
)
|
||
Disposal of property and equipment
|
16,874
|
|
|
7,092
|
|
||
Purchases of intangible assets
|
(133,032
|
)
|
|
(141,959
|
)
|
||
Purchases of short-term investments
|
—
|
|
|
(584,400
|
)
|
||
Net cash used in investing activities
|
(185,740
|
)
|
|
(942,841
|
)
|
||
CASH FLOWS FROM FINANCING ACTIVITIES:
|
|
|
|
|
|
||
Payments made on demand notes payable, related party
|
—
|
|
|
(2,950,000
|
)
|
||
Proceeds from sale of common stock, net of costs
|
8,859,767
|
|
|
2,340,194
|
|
||
Proceeds from exercise of stock options
|
360,225
|
|
|
161,265
|
|
||
Payments for debt issuance costs
|
—
|
|
|
(9,668
|
)
|
||
Net cash (used in) provided by financing activities
|
9,219,992
|
|
|
(458,209
|
)
|
||
Net increase (decrease) in cash and cash equivalents
|
4,300,493
|
|
|
(6,527,866
|
)
|
||
Cash and cash equivalents, beginning of the year
|
1,186,033
|
|
|
7,713,899
|
|
||
Cash and cash equivalents, end of the year
|
$
|
5,486,526
|
|
|
$
|
1,186,033
|
|
Cash paid for interest
|
$
|
121,742
|
|
|
$
|
324,885
|
|
|
2015
|
|
2014
|
||||
Products:
|
|
|
|
|
|
||
Cogeneration
|
$
|
7,882,838
|
|
|
$
|
5,364,810
|
|
Chiller & Heat Pump
|
2,172,399
|
|
|
3,260,224
|
|
||
Total Product Revenue
|
10,055,237
|
|
|
8,625,034
|
|
||
Services:
|
|
|
|
||||
Service contracts and related part sales
|
7,832,181
|
|
|
7,438,125
|
|
||
Installations
|
3,555,239
|
|
|
3,279,505
|
|
||
Total Service Revenue
|
11,387,420
|
|
|
10,717,630
|
|
||
Total Revenue
|
$
|
21,442,657
|
|
|
$
|
19,342,664
|
|
|
2015
|
|
2014
|
||||
Loss available to stockholders
|
$
|
(2,727,413
|
)
|
|
$
|
(3,745,812
|
)
|
Weighted average shares outstanding - Basic and diluted
|
16,860,453
|
|
|
15,607,897
|
|
||
Basic and diluted loss per share
|
$
|
(0.16
|
)
|
|
$
|
(0.24
|
)
|
|
|
|
|
||||
Anti-dilutive shares underlying stock options outstanding
|
1,268,200
|
|
|
1,356,325
|
|
||
Anti-dilutive convertible debentures
|
890,207
|
|
|
555,556
|
|
|
2015
|
|
2014
|
||||
Gross raw materials
|
$
|
5,618,853
|
|
|
$
|
4,348,786
|
|
Less - reserves
|
(293,000
|
)
|
|
(300,000
|
)
|
||
Net raw materials
|
5,325,853
|
|
|
4,048,786
|
|
||
Work-in-process
|
124,845
|
|
|
22,250
|
|
||
Finished goods
|
232,345
|
|
|
19,185
|
|
||
|
$
|
5,683,043
|
|
|
$
|
4,090,221
|
|
|
Product
Certifications
|
|
Patents
|
|
Developed Technology
|
|
Trademarks
|
|
Total
|
||||||||||
Balance at December 31, 2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Intangible assets
|
$
|
514,616
|
|
|
$
|
603,915
|
|
|
$
|
240,000
|
|
|
$
|
4,775
|
|
|
$
|
1,363,306
|
|
Less - accumulated amortization
|
(182,931
|
)
|
|
(91,764
|
)
|
|
(44,000
|
)
|
|
—
|
|
|
(318,695
|
)
|
|||||
|
$
|
331,685
|
|
|
$
|
512,151
|
|
|
$
|
196,000
|
|
|
$
|
4,775
|
|
|
$
|
1,044,611
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Balance at December 31, 2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Intangible assets
|
$
|
475,344
|
|
|
$
|
514,930
|
|
|
240,000
|
|
|
—
|
|
|
$
|
1,230,274
|
|
||
Less - accumulated amortization
|
(128,732
|
)
|
|
(62,242
|
)
|
|
(28,000
|
)
|
|
—
|
|
|
(218,974
|
)
|
|||||
|
$
|
346,612
|
|
|
$
|
452,688
|
|
|
$
|
212,000
|
|
|
$
|
—
|
|
|
$
|
1,011,300
|
|
2016
|
$
|
153,278
|
|
2017
|
153,278
|
|
|
2018
|
147,081
|
|
|
2019
|
130,430
|
|
|
2020
|
124,518
|
|
|
Thereafter
|
336,026
|
|
|
|
$
|
1,044,611
|
|
|
Estimated Useful
Life (in Years)
|
|
2015
|
|
2014
|
||||
Machinery and equipment
|
5 - 7 years
|
|
$
|
953,081
|
|
|
$
|
936,705
|
|
Furniture and fixtures
|
5 years
|
|
113,842
|
|
|
99,346
|
|
||
Computer software
|
3 - 5 years
|
|
67,215
|
|
|
67,215
|
|
||
Leasehold improvements
|
*
|
|
437,341
|
|
|
427,791
|
|
||
|
|
|
1,571,479
|
|
|
1,531,057
|
|
||
Less - accumulated depreciation and amortization
|
|
|
(1,027,725
|
)
|
|
(872,636
|
)
|
||
Net property, plant and equipment
|
|
|
$
|
543,754
|
|
|
$
|
658,421
|
|
Years Ending December 31,
|
|
Amount
|
||
2016
|
|
$
|
621,516
|
|
2017
|
|
742,944
|
|
|
2018
|
|
568,221
|
|
|
2019
|
|
506,432
|
|
|
2020
|
|
513,742
|
|
|
2021 and thereafter
|
|
1,722,042
|
|
|
Total
|
|
$
|
4,674,897
|
|
Warranty reserve, December 31, 2013
|
$
|
95,000
|
|
Warranty provision for units sold
|
207,583
|
|
|
Costs of warranty incurred
|
(155,583
|
)
|
|
Warranty reserve, December 31, 2014
|
147,000
|
|
|
Warranty provision for units sold
|
87,690
|
|
|
Costs of warranty incurred
|
(124,690
|
)
|
|
Warranty reserve, December 31, 2015
|
$
|
110,000
|
|
Common Stock Options
|
Number of
Options
|
|
Exercise
Price Per
Share
|
|
Weighted
Average Exercise
Price
|
|
Weighted
Average Remaining
Life
|
|
Aggregate
Intrinsic
Value
|
|||||
Outstanding, December 31, 2014
|
1,356,325
|
|
|
$1.20-$5.39
|
|
$
|
2.77
|
|
|
5.12 years
|
|
$
|
3,618,935
|
|
Granted
|
165,000
|
|
|
$3.39-$4.05
|
|
3.43
|
|
|
|
|
|
|
||
Exercised
|
(222,375
|
)
|
|
$1.20-$2.60
|
|
1.62
|
|
|
|
|
|
|
||
Canceled and forfeited
|
(18,250
|
)
|
|
$2.60-$4.50
|
|
3.52
|
|
|
|
|
|
|
||
Expired
|
(12,500
|
)
|
|
$1.20
|
|
1.20
|
|
|
|
|
|
|
||
Outstanding, December 31, 2015
|
1,268,200
|
|
|
$1.20-$5.39
|
|
$
|
3.06
|
|
|
6.01 years
|
|
$
|
985,578
|
|
Exercisable, December 31, 2015
|
841,650
|
|
|
|
|
$
|
2.48
|
|
|
|
|
$
|
978,640
|
|
Vested and expected to vest, December 31, 2015
|
1,268,200
|
|
|
|
|
$
|
3.06
|
|
|
|
|
$
|
985,578
|
|
Stock option awards:
|
|
2015
|
|
2014
|
Expected life
|
|
6.25 years
|
|
6.25 years
|
Risk-free interest rate
|
|
1.63%-1.67%
|
|
1.51%
|
Expected volatility
|
|
32.4%-32.6%
|
|
22.7%-32.3%
|
|
Number of
Restricted
Stock
|
|
Weighted
Average
Grant Date
Fair Value
|
|||
Unvested, December 31, 2014
|
163,350
|
|
|
$
|
1.31
|
|
Granted
|
—
|
|
|
—
|
|
|
Vested
|
—
|
|
|
—
|
|
|
Forfeited
|
—
|
|
|
—
|
|
|
Unvested, December 31, 2015
|
163,350
|
|
|
$
|
1.31
|
|
Common Stock Options
|
Number of
Options
|
|
Exercise
Price Per
Share
|
|
Weighted
Average Exercise
Price
|
|
Weighted
Average Remaining
Life
|
|
Aggregate
Intrinsic
Value
|
||||||
Outstanding, December 31, 2014
|
675,000
|
|
|
$0.10-$0.50
|
|
|
$
|
0.32
|
|
|
6.56 years
|
|
$
|
120,000
|
|
Granted
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
||
Exercised
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
||
Canceled and forfeited
|
(25,000
|
)
|
|
0.50
|
|
|
0.50
|
|
|
|
|
|
|
||
Expired
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
||
Outstanding, December 31, 2015
|
650,000
|
|
|
$0.10-$0.50
|
|
|
$
|
0.32
|
|
|
5.04 years
|
|
$
|
120,000
|
|
Exercisable, December 31, 2015
|
262,500
|
|
|
|
|
|
$
|
0.50
|
|
|
|
|
$
|
—
|
|
Vested and expected to vest, December 31, 2015
|
650,000
|
|
|
|
|
|
$
|
0.32
|
|
|
|
|
$
|
120,000
|
|
Stock option awards:
|
|
Expected life
|
6.25 years
|
Risk-free interest rate
|
1.65%
|
Expected volatility
|
35.2%
|
|
Number of
Restricted
Stock
|
|
Weighted
Average
Grant Date
Fair Value
|
|||
Unvested, December 31, 2014
|
310,000
|
|
|
$
|
0.10
|
|
Granted
|
—
|
|
|
—
|
|
|
Vested
|
—
|
|
|
—
|
|
|
Forfeited
|
(150,000
|
)
|
|
0.10
|
|
|
Unvested, December 31, 2015
|
160,000
|
|
|
$
|
0.10
|
|
|
|
|
2015
|
|
2014
|
||||
Pre-tax book income
|
|
$
|
(2,800,960
|
)
|
|
$
|
(3,870,952
|
)
|
|
Expected tax at 34%
|
|
(952,326
|
)
|
|
(1,316,123
|
)
|
|||
|
|
|
|
|
|
||||
Permanent differences:
|
|
|
|
|
|||||
|
Machinery & equipment
|
|
5,251
|
|
|
6,492
|
|
||
|
Other
|
|
444
|
|
|
36
|
|
||
|
|
|
|
|
|
||||
State taxes:
|
|
|
|
|
|||||
|
Current
|
|
—
|
|
|
—
|
|
||
|
Deferred
|
|
120,931
|
|
|
(177,412
|
)
|
||
|
|
|
|
|
|
||||
Other items:
|
|
|
|
|
|||||
|
Federal research and development credits
|
|
(16,504
|
)
|
|
—
|
|
||
|
Change in valuation allowance
|
|
(120,931
|
)
|
|
177,412
|
|
||
|
Deferred tax past year true-up's
|
|
(47,242
|
)
|
|
132
|
|
||
|
|
|
|
|
|
||||
Unbenefited operating losses
|
|
1,010,377
|
|
|
1,309,463
|
|
|||
Income tax provision
|
|
$
|
—
|
|
|
$
|
—
|
|
|
2015
|
|
2014
|
||||
Net operating loss carryforwards
|
$
|
6,734,000
|
|
|
$
|
6,356,000
|
|
R&D and ITC credit carryforwards
|
133,000
|
|
|
—
|
|
||
Accrued expenses and other
|
1,297,000
|
|
|
1,051,000
|
|
||
Accounts receivable
|
19,000
|
|
|
19,000
|
|
||
Inventory
|
250,000
|
|
|
207,000
|
|
||
Property, plant and equipment
|
119,000
|
|
|
138,000
|
|
||
Deferred tax assets
|
8,552,000
|
|
|
7,771,000
|
|
||
Valuation allowance
|
(8,552,000
|
)
|
|
(7,771,000
|
)
|
||
Deferred tax assets, net
|
$
|
—
|
|
|
$
|
—
|
|
“Company”:
|
Tecogen Inc., a Delaware corporation
|
“Holder”:
|
|
“Common Stock”:
|
Common Stock of the Company
|
Number of shares of Common Stock initially issuable on exercise of this Warrant (subject to adjustment):
|
shares
|
Price paid to purchase Warrant:
|
|
“Exercise Price” per share of Common Stock (subject to adjustment):
|
|
“Date of Issuance” of this Warrant:
|
|
“Expiration Date” of this Warrant
|
|
1.
|
I have reviewed this Annual Report on Form 10-K of Tecogen Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
1.
|
I have reviewed this Annual Report on Form 10-K of Tecogen Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
1.
|
I have reviewed this Annual Report on Form 10-K of Tecogen Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
1.
|
The Annual Report on Form 10-K of the Company for the year ended
December 31, 2015
, or the Report, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|